Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on December 14, 2018, covering events occurring on December 10, 2018. The registrant is a Delaware corporation headquartered in San Diego, CA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
Dr. Stanley Tennant resigned as a director of the Company for personal reasons, effective December 31, 2018. The resignation was not the result of any disagreement with the Company, its management, or the Board of Directors.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the director departure.
Investor Verification Checklist
- Confirm the effective date of Dr. Tennant's resignation (December 31, 2018).
- Verify if a replacement director has been appointed to fill the vacancy.
- Review subsequent filings for any impact on the Board's composition or committee assignments.